Sotera Health (SHC) Osake Kurssi
Sotera Health Kurssi
Viimeisten 7 vuoden aikana Sotera Healthn liikevaihto kasvoi 6,6 % vuodessa ja ylsi 1,16 Mrd. USD:een. Osakekohtainen tulos on laskenut 10,2 % vuodessa viimeisten 4 vuoden aikana. Sotera Healthn nettomarginaali 6,7 % on laskenut verrattuna 12,5 %:iin muutama vuosi sitten. Sotera Healthn 12 kuukauden konsensustavoitehinta on 19,00 USD, noin yli kurssia 18,7 %. 15 analyytikosta 12 suosittaa ostoa — kokonaiskonsensus on Osta.
Sotera Health osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Sotera Health liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Sotera Health -osakkeesta
The business model of Sotera Health Co revolves around providing sterilization, laboratory testing, and advisory services to support the healthcare industry. Sotera Health Co ensures the safety and quality of medical devices, pharmaceuticals, and tissue products through their various offerings. By utilizing state-of-the-art facilities and expertise, Sotera Health Co aims to contribute to the overall well-being of patients and enable their clients to deliver reliable and effective healthcare solutions. With a focus on enhancing patient outcomes and meeting regulatory requirements, Sotera Health Co plays a crucial role in maintaining the integrity of the healthcare supply chain.
Sotera Health Co is primarily active in the healthcare and life sciences industries.
The main competitors of Sotera Health Co in the market include Sterigenics, STERIS Corporation, and Nordion Inc. These companies operate in the same industry as Sotera Health Co, which specializes in providing sterilization, lab testing, and advisory services to the healthcare industry. Competing with these established players, Sotera Health Co aims to differentiate itself by delivering innovative solutions, maintaining strict quality standards, and offering excellent customer service.
Sotera Health Co, a leading global provider of mission-critical sterilization and lab testing services, has a rich history and background. Established in 1945 as Sterigenics, the company has evolved over the years to become a trusted partner in the healthcare industry. In 2019, Sterigenics merged with Nelson Labs and Nordion to form Sotera Health Co. With over 75 years of experience, Sotera Health Co has established itself as a market leader, offering comprehensive sterilization solutions, laboratory services, and radiation technologies. Guided by its commitment to improving global health, the company continues to innovate and provide vital support to pharmaceutical, medical device, and biotechnology companies worldwide.
Sotera Health Co has achieved several significant milestones in its journey. The company has successfully expanded its global reach and industry leadership. Sotera Health Co has made strategic acquisitions and partnerships, allowing it to enhance its services and strengthen its position in the healthcare industry. Furthermore, Sotera Health Co has consistently demonstrated its commitment to innovation and quality, earning various certifications and accreditations. Through its tireless efforts, Sotera Health Co has established itself as a trusted and reliable provider of comprehensive health sterilization, lab testing, and advisory services. These achievements reflect the company's dedication to excellence and drive for continuous improvement.
Sotera Health Co is primarily present in the United States of America.
Sotera Health Co represents a strong commitment to values and corporate philosophy. The company is dedicated to improving global health and safety through its integrated solutions and services. Sotera Health prioritizes quality, excellence, and integrity in all aspects of its operations. With a customer-centric approach, the company aims to deliver innovative and reliable solutions to its clients worldwide. Sotera Health Co embraces a collaborative and inclusive culture, fostering teamwork and diversity among its employees. By constantly striving for excellence, Sotera Health Co continues to establish itself as a leading player in the healthcare industry.
Analyytikot asettavat tällä hetkellä Sotera Health-osakkeelle keskimääräisen tavoitehinnan 19,00 USD (mediaani: 19,00 USD), mikä merkitsee +18,7 % viimeisimpään hintaan verrattuna. Konsensus perustuu 15 analyytikkoarvioon.
15 analyytikkoa arvioi tällä hetkellä Sotera Health-osaketta: 12 suosittaa ostoa, 2 pitoa ja 1 myyntiä. Vuodelle 2026 analyytikot odottavat Sotera Health-yhtiöltä 1,25 Mrd. USD liikevaihtoa ja 0,98 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Sotera Health-osake noteerataan hintaan 14,35 EUR (16,01 USD).
Sotera Health-osake (SHC) on listattuna 2 pörssissä, muun muassa: NASDAQ (SHC), München (SH5.MU).
The company Sotera Health Co is a leading company in the field of infection disease therapy in the medical technology industry. The company offers its customers a wide range of products and services to ensure the safety of medical devices and therapy procedures. The core business areas of the company are sterilization of medical devices, supply of gamma and electron beam technologies, and development of innovative methods for pathogen inactivation. The company operates 80 locations worldwide and serves over 5,800 customers in over 50 countries. The company provides medical sterilization services to ensure that products are free from contamination, bacteria, and viruses. These services are offered by the subsidiary Sterigenics International LLC, which provides medical sterilization services in North and South America, Europe, and Asia. Another subsidiary of Sotera Health Co is Nordion, a leading provider of gamma and electron beam technologies. The company offers innovations and services to customers in the medical technology, food and agriculture industries, as well as government agencies, to improve their radiation processes and applications. With the subsidiary Steri-Tek, Sotera Health Co also provides innovative methods for pathogen inactivation, including UV light and laser-controlled processes that enable effective disinfection of medical devices and products such as masks. In addition to these business areas, Sotera Health also operates two business units, Nelson Laboratories and Sotera Health Consulting. These business units offer services in the areas of microbiology, chemical and physical analysis, biocompatibility testing, and consulting to support customers in the medical and biotech industries. Overall, the business model of Sotera Health Co is focused on ensuring the safety and quality of medical devices and treatment procedures. The company offers a wide range of services and technologies to support customers in the medical technology, food and agriculture industries, as well as government agencies worldwide. The products and services of Sotera Health Co are crucial for the safety and health of patients worldwide.
odotettu liikevaihto Sotera Health on 1,25 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Sotera Health on 281,85 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Sotera Health:n hinta-voitto-suhde (P/E) on tällä hetkellä 16,27. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Sotera Health-osakkeen arvostusta.
Sotera Health:n hinta-myynti-suhde (P/S) on tällä hetkellä 3,68. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Sotera Health-osakkeen arvostuskennuslukuna.
Sotera Health:n Eulpool-laatuscore on 4/10.
Sotera Health:n ISIN on US83601L1026. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Sotera Health:n ticker on SHC. Tämä pörssinoteeraus käytetään Sotera Health-osakkeiden kauppaan pörssissä.
Sotera Health osake
Sotera Health vertaisryhmä
Sotera Health Ticker
Sotera Health FIGI
Kaikki tunnusluvut ja syvällinen analyysi Sotera Health:sta
Meidän osakeanalyysimme Sotera Health-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Sotera Health:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: